SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amylin Pharmaceuticals, Inc. Release: BYDUREON™ Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients With Type 2 Diabetes